Rivastigmine tartrate ( ENA-713; SDZ ENA-713 )

Catalog No. M11179 CAS No. 129101-54-8

An acetylcholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
25MG	42	In Stock
50MG	50	In Stock
100MG	73	In Stock
200MG	97	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Rivastigmine tartrate
Note

Research use only, not for human use.
Brief Description

An acetylcholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase.
Description

An acetylcholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase; a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer's type and dementia due to Parkinson's disease.Alzheimer's Disease Approved
Synonyms

ENA-713; SDZ ENA-713
Pathway

Metabolic Enzyme/Protease
Target

AChE
Recptor

AChR
Research Area

Neurological Disease
Indication

Alzheimer Disease

Chemical Information

CAS Number

129101-54-8
Formula Weight

400.42
Molecular Formula

C18H28N2O8
Purity

>98% (HPLC)
Solubility

10 mM in DMSO
SMILES

CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
Chemical Name

Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1)

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Polinsky RJ. et al. Clin Ther. 1998 Jul-Aug;20(4):634-47.
2. Kurz A, et al. Int J Clin Pract. 2009 May;63(5):799-805.
3. Stryjer R, et al. Clin Neuropharmacol. 2012 Jul-Aug;35(4):161-4.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

Product			Quantity Required*
Name *			E-mail Address *
Organization *			Phone Number
Remarks